Literature DB >> 17690862

[How come? What for? Why? Questions on the topic of "Botulinum toxin in urology"].

H Schulte-Baukloh1, H H Knispel.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17690862     DOI： 10.1007/s00120-007-1453-z

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  4 in total

1.  Botulinum toxin antibody testing: comparison between the mouse protection assay and the mouse lethality assay.

Authors:  D Dressler; G Dirnberger; K P Bhatia; A Irmer; N P Quinn; H Bigalke; C D Marsden
Journal:  Mov Disord       Date:  2000-09       Impact factor: 10.338

2.  Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: the role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test.

Authors:  Carla Cordivari; Vijay Peter Misra; Angela Vincent; Santiago Catania; Kailash P Bhatia; Andrew John Lees
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

3.  Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences.

Authors:  H Göschel; K Wohlfarth; J Frevert; R Dengler; H Bigalke
Journal:  Exp Neurol       Date:  1997-09       Impact factor: 5.330

4.  Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder.

Authors:  A Haferkamp; B Schurch; A Reitz; U Krengel; J Grosse; G Kramer; S Schumacher; P J Bastian; R Büttner; S C Müller; M Stöhrer
Journal:  Eur Urol       Date:  2004-12       Impact factor: 20.096
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.